At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
TMDX TransMedics Group, Inc.
Market Closed 05-17 16:00:00 EDT
137.98
+3.05
+2.26%
盘后137.90
-0.08-0.06%
19:55 EDT
High139.93
Low134.51
Vol827.22K
Open135.33
D1 Closing134.93
Amplitude4.02%
Mkt Cap4.54B
Tradable Cap4.40B
Total Shares32.94M
T/O114.22M
T/O Rate2.59%
Tradable Shares31.89M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Analysts Offer Insights on Healthcare Companies: TransMedics Group (TMDX), Fresenius Medical Care AG & Co. KGaA (GB:0H9X) and CompuGroup Medical (GB:0MSD)
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage; and OCS Liver for the preservation of donor livers. The company was founded in 1998 and is headquartered in Andover, Massachusetts.